HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 2005-0153v1 2005-0153v2 24/2/299    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goselink, H. M. Articles by Falkenburg, J.H. F. Search for Related Content PubMed PubMed Citation Articles by Goselink, H. M. Articles by Falkenburg, J.H. F.

TISSUE-SPECIFIC STEM CELLS

Cytokine-Dependent Proliferation of Human CD34⁺ Progenitor Cells in the Absence of Serum Is Suppressed by Their Progeny’s Production of Serine Proteinases

^a Laboratory of Experimental Hematology, Department of Hematology,
^b Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands

Key Words. Hematopoietic progenitor cells • Serum-free culture • Hematopoietic growth factor • Serine proteinase

Correspondence: Henriette M. Goselink, B.Sc., Department of Hematology, C2-R, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Telephone: +31-71-526-2271; Fax: +31-71-526-6755; e-mail: H.M.Goselink{at}lumc.nl

In this study, we demonstrate that the synthesis and release of serine proteinases by hematopoietic cells affects the in vitro proliferation of hematopoietic progenitor cells (HPCs) in response to proteins, including hematopoietic growth factors (HGFs), transferrin, insulin, and albumin in serum-free cultures. In serum-free cultures, bone marrow mononuclear cells or the CD34^– progeny of the CD34⁺ cells were shown to release the serine proteinases human neutrophil elastase (HNE), cathepsin G (Cath G), and proteinase 3 (Pr3). In the absence of serum, we showed that HNE, Cath G, and Pr3 rapidly and dose-dependently degraded HGF and other proteins present in the medium, resulting in decreased proliferation of HPCs. Addition of the serine proteinase inhibitors 1–proteinase inhibitor (1-PI) or the secretory leukocyte proteinase inhibitor (SLPI), but not leupeptin, aprotinin, or AEBSF (4-[2-aminoethyl]-benzenesulfonylfluoride hydrochloride), could completely prevent the degradation of proteins relevant to the growth of hematopoietic cells. Thus, the addition of serine proteinase inhibitors like 1-PI or SLPI may be critical for the expansion of CD34⁺ cells or gene transfer into CD34⁺ cells or other hematopoietic cells in vitro using serum-free media under good manufacturing practice conditions.

This article has been cited by other articles:

				D. Garwicz Neutrophil Serine Proteases: Future Therapeutic Targets in Patients with Severe Chronic Neutropenia and Leukemia? Stem Cells, September 1, 2006; 24(9): 2158 - 2159. [Full Text] [PDF]